ストックスクリーナーアプリを入手
2.19
2.23%
-0.05
アフターアワーズ：
2.15
-0.04
-1.83%
前日終値:
$2.24
開ける：
$2.24
24時間の取引高:
30,040
Relative Volume:
0.19
時価総額：
$6.63M
収益：
$3.91M
当期純損益:
$-11.65M
株価収益率:
-0.1777
EPS:
-12.3212
ネットキャッシュフロー:
$-11.51M
1週間 パフォーマンス:
-4.78%
1か月 パフォーマンス:
+11.73%
6か月 パフォーマンス:
-46.52%
1年 パフォーマンス:
-87.12%
1日の値動き範囲:
$2.11
$2.24
1週間の範囲:
$2.11
$2.40
52週間の値動き範囲:
$1.52
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Compare INBS vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.19 | 6.78M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
A fingerprint drug test company will discuss its FDA submission Sept. 24 - Stock Titan
Intelligent Bio Solutions submits FDA application for codeine test By Investing.com - Investing.com Australia
Intelligent Bio Solutions Files FDA 510(k) for U.S. Market Entry - Minichart
INBS Looks 7.4% Undervalued on GF Value™ Amid Challenging Price-to-Sales Dynamics - GuruFocus
Intelligent Bio Solutions submits FDA 510(k) for fingerprint drug screen after clinical studies show >98% accuracy - TradingView
Intelligent Bio Solutions submits FDA application for codeine test - Investing.com
Intelligent Bio Solutions Submits FDA 510(k) for Drug Screening System to Detect Codeine - Quiver Quantitative
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance - marketscreener.com
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market - benzinga.com
Intelligent Bio Solutions Raises Up to $15M in Private Placement - Minichart
Intelligent Bio Solutions Completes $5 Million Private Placement - TipRanks
Intelligent Bio Solutions Raises $5 Million in Private Placement With Warrants - TradingView
INBS|Intelligent Bio Solutions Inc|Price:2.300|Chg%:-0.170 - TradingKey
Intelligent Bio Solutions Inc. announced that it has received $4.999998 million in funding - marketscreener.com
Intelligent Bio Solutions posts >98% accuracy in multi-site study, targets Sept 2026 510(k) - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com
Intelligent Bio Solutions Inc. announced that it expects to receive $4.999998 million in funding - marketscreener.com
INBS Stock Draws Traders As FDA 510(k) Milestones Pile Up - StocksToTrade
INBS Stock Steadies As FDA Milestones And Revenue Growth Stack Up - timothysykes.com
INBS Looks 3.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions reports improved drug screening accuracy By Investing.com - Investing.com India
Intelligent Bio Solutions raises $5M in private placement By Investing.com - Investing.com Canada
Intelligent Bio Solutions reports improved drug screening accuracy - Investing.com
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission - The Manila Times
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - The Manila Times
A fingerprint drug test produced no false positives. Intelligent Bio Solutions expects an FDA filing in September. - Stock Titan
Press Release: Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules - Moomoo
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions earnings missed by $4.88, revenue fell short of estimates - Investing.com Canada
Intelligent (INBS) Range: Posts a 1.31% Loss to $2.63 in the Latest Reading; Chart View: $2.50 and $2.76 Define the Nearby Reference Levels in the Current UpdateSize Factor - vinanet.vn
Intelligent Bio Solutions completes clinical data collection for FDA 510(k) - scanx.trade
INBS Looks 0.4% Overvalued on GF Value™ - GuruFocus
Intelligent Bio Solutions Revenue Rises 38% to $4.2 Million in Fiscal 2026 - Moomoo
Intelligent Bio Solutions resolves all cybersecurity review items ahead of H2 2026 FDA filing - scanx.trade
Intelligent Bio Solutions revenue rises 38% to $4.2 million - grafa.com
BRIEF-Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - Bitget
Form 8K Intelligent Bio Solutions Inc For: 19 August By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
INBS FY26 Results: Revenue up 38% to $4.2M, margin expands to 48.6% - scanx.trade
Intelligent Bio Solutions Revenue Jumps 38% as Gross Margin Expands 778 Basis Points - Minichart
Intelligent Bio Solutions | 10-K: Annual report - Moomoo
Intelligent Bio Solutions Reports Fiscal 2026 Revenue Up 38% to $4.22M, Gross Margin 48.63% - TradingView
INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026 - TradingView
INTELLIGENT BIO SOLUTIONS INC. FY 2026: Revenue $4.22M, EPS $(8.44) — 10-K Summary - TradingView
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth - TradingView
Intelligent Bio (NASDAQ: INBS) warns on cash and survival - Stock Titan
Intelligent Bio Solutions grows to 502 customers as net loss widens to $12.5M - Stock Titan
Intelligent Bio Solutions Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Intelligent Bio Solutions (NASDAQ:INBS): Can Commercial Adoption Accelerate? - Kalkine Media
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? - TradingView
Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
2.29%
0.75%
大文字化:
|
ボリューム (24 時間):